Bill > HB872

This bill authorizes health care practitioners to prescribe undesignated single-use epinephrine auto-injectors for various state and county entities, including public schools, government offices, businesses, and other organizations. The legislation aims to increase access to epinephrine in case of severe allergic reactions (anaphylaxis) by allowing entities to stock these emergency medical devices. Specifically, the bill allows practitioners to prescribe epinephrine in the name of an organization, permits designated employees to administer the medication to individuals experiencing a severe allergic reaction (even without a prior diagnosis), and provides liability protection for those involved in prescribing, dispensing, or administering the epinephrine. The bill requires that employees who may administer epinephrine receive training on recognizing allergic reactions and proper administration techniques. The legislation is based on findings that food allergies are a leading cause of severe allergic reactions outside hospitals, and that timely administration of epinephrine can reduce the risk of fatal or debilitating outcomes. By enabling more widespread availability of epinephrine, the bill seeks to improve public safety and emergency medical response for individuals experiencing anaphylaxis.

Business and Industry, Health and Social Services

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=872&year=2026